Scratching the surface: Signaling and routing dynamics of the CSF3 receptor

Frontiers in Bioscience

Volumn 18, Issue 1, 2013, Pages 91-105

  Palande, Karishma ^a   Meenhuis, Annemarie ^a   Jevdjovic, Tanja ^a   Touw, Ivo Paul ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

CSF3 receptor; Deubiquitinating enzymes; Intracellular trafficking; JAK STAT signaling; Peroxiredoxin; Protein tyrosine phosphatase 1b; Review; Signal transduction; Signaling endosome; Suppressor of cytokine signaling

Indexed keywords

COLONY STIMULATING FACTOR RECEPTOR; CSF3R PROTEIN, HUMAN; ESCRT PROTEIN; JANUS KINASE; LYSINE; PROTEIN TYROSINE PHOSPHATASE 1B; PROTEIN TYROSINE PHOSPHATASE SHP 1; PROTEINASE; PTPN1 PROTEIN, HUMAN; PTPN6 PROTEIN, HUMAN; UBIQUITIN THIOLESTERASE; USP8 PROTEIN, HUMAN;

ACUTE GRANULOCYTIC LEUKEMIA; ANIMAL; ENDOCYTOSIS; GENETICS; HUMAN; LYSOSOME; METABOLISM; MOUSE; NEUTROPENIA; OXIDATION REDUCTION REACTION; PATHOPHYSIOLOGY; PHYSIOLOGY; REVIEW; SEVERE CONGENITAL NEUTROPENIA; SIGNAL TRANSDUCTION; UBIQUITINATION;

ANIMALS; ENDOCYTOSIS; ENDOPEPTIDASES; ENDOSOMAL SORTING COMPLEXES REQUIRED FOR TRANSPORT; HUMANS; JANUS KINASES; LEUKEMIA, MYELOID, ACUTE; LYSINE; LYSOSOMES; MICE; NEUTROPENIA; OXIDATION-REDUCTION; PROTEIN TYROSINE PHOSPHATASE, NON-RECEPTOR TYPE 1; PROTEIN TYROSINE PHOSPHATASE, NON-RECEPTOR TYPE 6; RECEPTORS, COLONY-STIMULATING FACTOR; SIGNAL TRANSDUCTION; UBIQUITIN THIOLESTERASE; UBIQUITINATION;

MLCS; MLOWN;

EID: 84878770579     PISSN: 27686701     EISSN: 27686698     Source Type: Journal    
DOI: 10.2741/4089     Document Type: Review

References (149)

1. G. D. Demetri and J. D. Griffin: Granulocyte colony-stimulating factor and its receptor. Blood, 78(11), 2791-808 (1991)
2. G. J. Lieschke: CSF-deficient mice - what have they taught us? Ciba Found Symp, 204, 60-74; discussion 74-7 (1997)
3. B. R. Avalos, J. C. Gasson, C. Hedvat, S. G. Quan, G. C. Baldwin, R. H. Weisbart, R. E. Williams, D. W. Golde and J. F. DiPersio: Human granulocyte colony-stimulating factor: biologic activities and receptor characterization on hematopoietic cells and small cell lung cancer cell lines. Blood, 75(4), 851-7 (1990)
4. K. Morishita, M. Tsuchiya, S. Asano, Y. Kaziro and S. Nagata: Chromosomal gene structure of human myeloperoxidase and regulation of its expression by granulocyte colony-stimulating factor. J Biol Chem, 262(31), 15208-13 (1987)
5. N. Sato, S. Asano, H. P. Koeffler, S. Yoshida, F. Takaku and O. Takatani: Identification of neutrophil alkaline phosphatase-inducing factor in cystic fluid of a human squamous cell carcinoma as granulocyte colony-stimulating factor. J Cell Physiol, 137(2), 272-6 (1988)
6. G. J. Lieschke, D. Grail, G. Hodgson, D. Metcalf, E. Stanley, C. Cheers, K. J. Fowler, S. Basu, Y. F. Zhan and A. R. Dunn: Mice lacking granulocyte colony-stimulating factor have chronic neutropenia, granulocyte and macrophage progenitor cell deficiency, and impaired neutrophil mobilization. Blood, 84(6), 1737-46 (1994)
7. F. Liu, H. Y. Wu, R. Wesselschmidt, T. Kornaga and D. C. Link: Impaired production and increased apoptosis of neutrophils in granulocyte colony-stimulating factor receptor-deficient mice. Immunity, 5(5), 491-501 (1996)
8. J. F. Bazan: Structural design and molecular evolution of a cytokine receptor superfamily. Proc Natl Acad Sci U S A, 87(18), 6934-8 (1990)
9. D. Cosman: The hematopoietin receptor superfamily. Cytokine, 5(2), 95-106 (1993)
10. H. Anaguchi, O. Hiraoka, K. Yamasaki, S. Naito and Y. Ota: Ligand binding characteristics of the carboxyl-terminal domain of the cytokine receptor homologous region of the granulocyte colony-stimulating factor receptor. J Biol Chem, 270(46), 27845-51 (1995)
11. R. Fukunaga, E. Ishizaka-Ikeda, C. Pan, Y. Seto and S. Nagata: Functional domains of the granulocyte colony-stimulating factor receptor. EMBO J, 10(10), 2855-65 (1991)
12. F. Dong, C. van Buitenen, K. Pouwels, L. H. Hoefsloot, B. Löwenberg and I. P. Touw: Distinct cytoplasmic regions of the human granulocyte colony-stimulating factor receptor involved in induction of proliferation and maturation. Mol Cell Biol, 13(12), 7774-81 (1993)
13. R. Fukunaga, E. Ishizaka-Ikeda and S. Nagata: Growth and differentiation signals mediated by different regions in the cytoplasmic domain of granulocyte colony-stimulating factor receptor. Cell, 74(6), 1079-87 (1993)
14. J. E. Layton and N. E. Hall: The interaction of G-CSF with its receptor. Front Biosci, 11, 3181-9 (2006)
15. S. E. Nicholson, U. Novak, S. F. Ziegler and J. E. Layton: Distinct regions of the granulocyte colony-stimulating factor receptor are required for tyrosine phosphorylation of the signaling molecules JAK2, Stat3, and p42, p44MAPK. Blood, 86(10), 3698-704 (1995)
16. S. E. Nicholson, A. C. Oates, A. G. Harpur, A. Ziemiecki, A. F. Wilks and J. E. Layton: Tyrosine kinase JAK1 is associated with the granulocyte-colony- stimulating factor receptor and both become tyrosine-phosphorylated after receptor activation. Proc Natl Acad Sci U S A, Apr 12;91(8):2985-8
17. 91(8), 2985-8 (1994)
18. K. Shimoda, J. Feng, H. Murakami, S. Nagata, D. Watling, N. C. Rogers, G. R. Stark, I. M. Kerr and J. N. Ihle: Jak1 plays an essential role for receptor phosphorylation and Stat activation in response to granulocyte colony-stimulating factor. Blood, 90(2), 597-604 (1997)
19. K. Shimoda, H. Iwasaki, S. Okamura, Y. Ohno, A. Kubota, F. Arima, T. Otsuka and Y. Niho: G-CSF induces tyrosine phosphorylation of the JAK2 protein in the human myeloid G-CSF responsive and proliferative cells, but not in mature neutrophils. Biochem Biophys Res Commun, 203(2), 922-8 (1994)
20. A. C. Ward, J. L. Monkhouse, X. F. Csar, I. P. Touw and P. A. Bello: The Src-like tyrosine kinase Hck is activated by granulocyte colony-stimulating factor (G-CSF) and docks to the activated G-CSF receptor. Biochem Biophys Res Commun, 251(1), 117-23 (1998)
21. R. M. Barge, J. P. de Koning, K. Pouwels, F. Dong, B. Löwenberg and I. P. Touw: Tryptophan 650 of human granulocyte colony-stimulating factor (G-CSF) receptor, implicated in the activation of JAK2, is also required for G-CSF-mediated activation of signaling complexes of the p21ras route. Blood, 87(6), 2148-53 (1996)
22. M. H. Hermans, G. J. van de Geijn, C. Antonissen, J. Gits, D. van Leeuwen, A. C. Ward and I. P. Touw: Signaling mechanisms coupled to tyrosines in the granulocyte colony-stimulating factor receptor orchestrate G-CSF-induced expansion of myeloid progenitor cells. Blood, 101(7), 2584-90 (2003)
23. I. P. Touw and G. J. van de Geijn: Granulocyte colony-stimulating factor and its receptor in normal myeloid cell development, leukemia and related blood cell disorders. Front Biosci, 12, 800-15 (2007)
24. A. C. Ward: The role of the granulocyte colony-stimulating factor receptor (G-CSF-R) in disease. Front Biosci, 12, 608-18 (2007)
25. R. Beekman and I. P. Touw: G-CSF and its receptor in myeloid malignancy. Blood, 115(25), 5131-6 (2010)
26. F. Dong, R. K. Brynes, N. Tidow, K. Welte, B. Löwenberg and I. P. Touw: Mutations in the Gene for the Granulocyte Colony-Stimulating-Factor Receptor in Patients with Acute Myeloid Leukemia Preceded by Severe Congenital Neutropenia. New Engl J Med, 333(8), 487-493 (1995)
27. F. Dong, D. C. Dale, M. A. Bonilla, M. Freedman, A. Fasth, H. J. Neijens, J. Palmblad, G. L. Briars, G. Carlsson, A. J. Veerman, K. Welte, B. Löwenberg and I. P. Touw: Mutations in the granulocyte colony-stimulating factor receptor gene in patients with severe congenital neutropenia. Leukemia, 11(1), 120-5 (1997)
28. M. T. Duvernay, C. M. Filipeanu and G. Wu: The regulatory mechanisms of export trafficking of G protein-coupled receptors. Cell Signal, 17(12), 1457-65 (2005)
29. I. Mellman and G. Warren: The road taken: past and future foundations of membrane traffic. Cell, 100(1), 99-112 (2000)
30. H. C. Meusser B, Jarosch E, Sommer T: ERAD: the long road to destruction. Nat Cell Biol, 7(8), 766-72 (2005)
31. L. H. Aarts, O. Roovers, A. C. Ward and I. P. Touw: Receptor activation and 2 distinct COOH-terminal motifs control G-CSF receptor distribution and internalization kinetics. Blood, 103(2), 571-9 (2004)
32. S. B. Helliwell, S. Losko and C. A. Kaiser: Components of a ubiquitin ligase complex specify polyubiquitination and intracellular trafficking of the general amino acid permease. J Cell Biol, 153(4), 649-62 (2001)
33. O. Soetens, J. O. De Craene and B. Andre: Ubiquitin is required for sorting to the vacuole of the yeast general amino acid permease, Gap1. J Biol Chem, 276(47), 43949-57 (2001)
34. A. Meenhuis, M. Irandoust, A. Wolfler, O. Roovers, M. Valkhof and I. P. Touw: Janus kinases promote cell-surface expression and provoke autonomous signalling from routing-defective G-CSF receptors. Biochem J, 417(3), 737-46 (2009)
35. D. J. Hilton, R. T. Richardson, W. S. Alexander, E. M. Viney, T. A. Willson, N. S. Sprigg, R. Starr, S. E. Nicholson, D. Metcalf and N. A. Nicola: Twenty proteins containing a C-terminal SOCS box form five structural classes. Proc Natl Acad Sci USA, 95(1), 114-9 (1998)
36. S. J. Erkeland, L. H. Aarts, M. Irandoust, O. Roovers, A. Klomp, M. Valkhof, J. Gits, S. Eyckerman, J. Tavernier and I. P. Touw: Novel role of WD40 and SOCS box protein-2 in steady-state distribution of granulocyte colony-stimulating factor receptor and G-CSF-controlled proliferation and differentiation signaling. Oncogene, 26(14), 1985-94 (2007)
37. H. Nara, T. Onoda, M. Rahman, A. Araki, F. M. Juliana, N. Tanaka and H. Asao: WSB-1, a novel IL-21 receptor binding molecule, enhances the maturation of IL-21 receptor. Cell Immunol, 269(1), 54-9 (2011)
38. H. Nara, T. Onoda, M. Rahman, A. Araki, F. M. Juliana, N. Tanaka and H. Asao: Regulation of interleukin-21 receptor expression and its signal transduction by WSB-2. Biochem Biophys Res Commun, 392(2), 171-7 (2010)
39. X. Jing, J. Infante, R. G. Nachtman and R. Jurecic: E3 ligase FLRF (Rnf41) regulates differentiation of hematopoietic progenitors by governing steady-state levels of cytokine and retinoic acid receptors. Exp Hematol, 36(9), 1110-20 (2008)
40. J. Wauman, L. De Ceuninck, N. Vanderroost, S. Lievens and J. Tavernier: RNF41 (Nrdp1) controls type 1 cytokine receptor degradation and ectodomain shedding. J Cell Sci, 124(Pt 6), 921-32 (2011)
41. C. Haan, S. Kreis, C. Margue and I. Behrmann: Jaks and cytokine receptors - an intimate relationship. Biochem Pharmacol, 72(11), 1538-46 (2006)
42. S. Pelletier, S. Gingras, M. Funakoshi-Tago, S. Howell and J. N. Ihle: Two domains of the erythropoietin receptor are sufficient for Jak2 binding/activation and function. Mol Cell Biol, 26(22), 8527-38 (2006)
43. S. Polo and P. P. Di Fiore: Endocytosis conducts the cell signaling orchestra. Cell, 124(5), 897-900 (2006)
44. G. Scita and P. P. Di Fiore: The endocytic matrix. Nature, 463(7280), 464-73 (2010)
45. A. Sorkin and M. von Zastrow: Endocytosis and signalling: intertwining molecular networks. Nat Rev Mol Cell Biol, 10(9), 609-22 (2009)
46. Y. Zwang and Y. Yarden: Systems biology of growth factor-induced receptor endocytosis. Traffic, 10(4), 349-63 (2009)
47. C. Raiborg and H. Stenmark: The ESCRT machinery in endosomal sorting of ubiquitylated membrane proteins. Nature, 458(7237), 445-52 (2009)
48. K. Hofmann and L. Falquet: A ubiquitin-interacting motif conserved in components of the proteasomal and lysosomal protein degradation systems. Trends Biochem Sci, 26(6), 347-50 (2001)
49. M. Kazazic, V. Bertelsen, K. W. Pedersen, T. T. Vuong, M. V. Grandal, M. S. Rodland, L. M. Traub, E. Stang and I. H. Madshus: Epsin 1 is involved in recruitment of ubiquitinated EGF receptors into clathrin-coated pits. Traffic, 10(2), 235-45 (2009)
50. I. H. Madshus and E. Stang: Internalization and intracellular sorting of the EGF receptor: a model for understanding the mechanisms of receptor trafficking. J Cell Sci, 122(Pt 19), 3433-9 (2009)
51. E. Stang, F. D. Blystad, M. Kazazic, V. Bertelsen, T. Brodahl, C. Raiborg, H. Stenmark and I. H. Madshus: Cbl-dependent ubiquitination is required for progression of EGF receptors into clathrin-coated pits. Mol Biol Cell, 15(8), 3591-604 (2004)
52. K. Haglund, S. Sigismund, S. Polo, I. Szymkiewicz, P. P. Di Fiore and I. Dikic: Multiple monoubiquitination of RTKs is sufficient for their endocytosis and degradation. Nat Cell Biol, 5(5), 461-6 (2003)
53. J. A. Hanover, M. C. Willingham and I. Pastan: Kinetics of transit of transferrin and epidermal growth factor through clathrin-coated membranes. Cell, 39(2 Pt 1), 283-93 (1984)
54. W. H. Levkowitz G, Zamir E, Kam Z, Oved S, Langdon WY, Beguinot L, Geiger B, Yarden Y: c-Cbl/Sli-1 regulates endocytic sorting and ubiquitination of the epidermal growth factor receptor. Genes Dev, 12(23), 3663-74 (1998)
55. K. Umebayashi, H. Stenmark and T. Yoshimori: Ubc4/5 and c-Cbl continue to ubiquitinate EGF receptor after internalization to facilitate polyubiquitination and degradation. Mol Biol Cell, 19(8), 3454-62 (2008)
56. A. Grishin, S. Sinha, V. Roginskaya, M. J. Boyer, J. Gomez-Cambronero, S. Zuo, T. Kurosaki, G. Romero and S. J. Corey: Involvement of Shc and Cbl-PI 3-kinase in Lyn-dependent proliferative signaling pathways for G-CSF. Oncogene, 19(1), 97-105 (2000)
57. L. Wang, W. A. Rudert, I. Loutaev, V. Roginskaya and S. J. Corey: Repression of c-Cbl leads to enhanced G-CSF Jak-STAT signaling without increased cell proliferation. Oncogene, 21(34), 5346-55 (2002)
58. F. Gesbert, V. Malarde and A. Dautry-Varsat: Ubiquitination of the common cytokine receptor gammac and regulation of expression by an ubiquitination/deubiquitination machinery. Biochem Biophys Res Commun, 334(2), 474-80 (2005)
59. S. J. Saur, V. Sangkhae, A. E. Geddis, K. Kaushansky and I. S. Hitchcock: Ubiquitination and degradation of the thrombopoietin receptor c-Mpl. Blood, 115(6), 1254-63 (2010)
60. Y. Tanaka, N. Tanaka, Y. Saeki, K. Tanaka, M. Murakami, T. Hirano, N. Ishii and K. Sugamura: c-Cbl-dependent monoubiquitination and lysosomal degradation of gp130. Mol Cell Biol, 28(15), 4805-18 (2008)
61. L. Meyer, B. Deau, H. Forejtnikova, D. Dumenil, F. Margottin-Goguet, C. Lacombe, P. Mayeux and F. Verdier: beta-Trcp mediates ubiquitination and degradation of the erythropoietin receptor and controls cell proliferation. Blood, 109(12), 5215-22 (2007)
62. A. D. Friedman, D. Nimbalkar and F. W. Quelle: Erythropoietin receptors associate with a ubiquitin ligase, p33RUL, and require its activity for erythropoietin-induced proliferation. J Biol Chem, 278(29), 26851-61 (2003)
63. K. G. Kumar, J. J. Krolewski and S. Y. Fuchs: Phosphorylation and specific ubiquitin acceptor sites are required for ubiquitination and degradation of the IFNAR1 subunit of type I interferon receptor. J Biol Chem, 279(45), 46614-20 (2004)
64. G. Wu, G. Xu, B. A. Schulman, P. D. Jeffrey, J. W. Harper and N. P. Pavletich: Structure of a beta-TrCP1-Skp1-beta-catenin complex: destruction motif binding and lysine specificity of the SCF(beta-TrCP1) ubiquitin ligase. Mol Cell, 11(6), 1445-56 (2003)
65. K. G. Kumar, H. Barriere, C. J. Carbone, J. Liu, G. Swaminathan, P. Xu, Y. Li, D. P. Baker, J. Peng, G. L. Lukacs and S. Y. Fuchs: Site-specific ubiquitination exposes a linear motif to promote interferon-alpha receptor endocytosis. J Cell Biol, 179(5), 935-50 (2007)
66. S. Y. Fuchs, V. S. Spiegelman and K. G. Kumar: The many faces of beta-TrCP E3 ubiquitin ligases: reflections in the magic mirror of cancer. Oncogene, 23(11), 2028-36 (2004)
67. P. van Kerkhof, J. Putters and G. J. Strous: The ubiquitin ligase SCF(betaTrCP) regulates the degradation of the growth hormone receptor. J Biol Chem, 282(28), 20475-83 (2007)
68. A. Wölfler, M. Irandoust, A. Meenhuis, J. Gits, O. Roovers and I. P. Touw: Site-specific ubiquitination determines lysosomal sorting and signal attenuation of the granulocyte colony-stimulating factor receptor. Traffic, 10(8), 1168-79 (2009)
69. M. Hortner, U. Nielsch, L. M. Mayr, J. A. Johnston, P. C. Heinrich and S. Haan: Suppressor of cytokine signaling-3 is recruited to the activated granulocyte-colony stimulating factor receptor and modulates its signal transduction. J Immunol, 169(3), 1219-27 (2002)
70. C. K. Lee, R. Raz, R. Gimeno, R. Gertner, B. Wistinghausen, K. Takeshita, R. A. DePinho and D. E. Levy: STAT3 is a negative regulator of granulopoiesis but is not required for G-CSF-dependent differentiation. Immunity, 17(1), 63-72 (2002)
71. G. J. van de Geijn, J. Gits, L. H. Aarts, C. Heijmans-Antonissen and I. P. Touw: G-CSF receptor truncations found in SCN/AML relieve SOCS3-controlled inhibition of STAT5 but leave suppression of STAT3 intact. Blood, 104(3), 667 (2004)
72. M. Fujimoto and T. Naka: Regulation of cytokine signaling by SOCS family molecules. Trends Immunol, 24(12), 659-66 (2003)
73. A. Yoshimura, T. Naka and M. Kubo: SOCS proteins, cytokine signalling and immune regulation. Nat Rev Immunol, 7(6), 454-65 (2007)
74. B. T. Kile, B. A. Schulman, W. S. Alexander, N. A. Nicola, H. M. Martin and D. J. Hilton: The SOCS box: a tale of destruction and degradation. Trends Biochem Sci, 27(5), 235-41 (2002)
75. A. Sasaki, H. Yasukawa, A. Suzuki, S. Kamizono, T. Syoda, I. Kinjyo, M. Sasaki, J. A. Johnston and A. Yoshimura: Cytokine-inducible SH2 protein-3 (CIS3/SOCS3) inhibits Janus tyrosine kinase by binding through the N-terminal kinase inhibitory region as well as SH2 domain. Genes Cells, 4(6), 339-51 (1999)
76. K. Boyle, P. Egan, S. Rakar, T. A. Willson, I. P. Wicks, D. Metcalf, D. J. Hilton, N. A. Nicola, W. S. Alexander, A. W. Roberts and L. Robb: The SOCS box of suppressor of cytokine signaling-3 contributes to the control of G-CSF responsiveness in vivo. Blood, 110(5), 1466-74 (2007)
77. G. J. van de Geijn, J. Gits and I. P. Touw: Distinct activities of suppressor of cytokine signaling (SOCS) proteins and involvement of the SOCS box in controlling G-CSF signaling. J Leukoc Biol, 76(1), 237-44 (2004)
78. T. Kamura, K. Maenaka, S. Kotoshiba, M. Matsumoto, D. Kohda, R. C. Conaway, J. W. Conaway and K. I. Nakayama: VHL-box and SOCS-box domains determine binding specificity for Cul2-Rbx1 and Cul5-Rbx2 modules of ubiquitin ligases. Genes Dev, 18(24), 3055-65 (2004)
79. M. I. Irandoust, L. H. Aarts, O. Roovers, J. Gits, S. J. Erkeland and I. P. Touw: Suppressor of cytokine signaling 3 controls lysosomal routing of G-CSF receptor. EMBO J, 26(7), 1782-93 (2007)
80. R. V. Stahelin, F. Long, K. Diraviyam, K. S. Bruzik, D. Murray and W. Cho: Phosphatidylinositol 3-phosphate induces the membrane penetration of the FYVE domains of Vps27p and Hrs. J Biol Chem, 277(29), 26379-88 (2002)
81. T. Slagsvold, R. Aasland, S. Hirano, K. G. Bache, C. Raiborg, D. Trambaiolo, S. Wakatsuki and H. Stenmark: Eap45 in mammalian ESCRT-II binds ubiquitin via a phosphoinositide-interacting GLUE domain. J Biol Chem, 280(20), 19600-6 (2005)
82. T. Slagsvold, K. Pattni, L. Malerod and H. Stenmark: Endosomal and non-endosomal functions of ESCRT proteins. Trends Cell Biol, 16(6), 317-26 (2006)
83. M. Agromayor and J. Martin-Serrano: Interaction of AMSH with ESCRT-III and deubiquitination of endosomal cargo. J Biol Chem, 281(32), 23083-91 (2006)
84. T. Kaneko, T. Kumasaka, T. Ganbe, T. Sato, K. Miyazawa, N. Kitamura and N. Tanaka: Structural insight into modest binding of a non-PXXP ligand to the signal transducing adaptor molecule-2 Src homology 3 domain. J Biol Chem, 278(48), 48162-8 (2003)
85. M. Kato, K. Miyazawa and N. Kitamura: A deubiquitinating enzyme UBPY interacts with the Src homology 3 domain of Hrs-binding protein via a novel binding motif PX(V/I)(D/N)RXXKP. J Biol Chem, 275(48), 37481-7 (2000)
86. P. E. Row, H. Liu, S. Hayes, R. Welchman, P. Charalabous, K. Hofmann, M. J. Clague, C. M. Sanderson and S. Urbe: The MIT domain of UBPY constitutes a CHMP binding and endosomal localization signal required for efficient epidermal growth factor receptor degradation. J Biol Chem, 282(42), 30929-37 (2007)
87. J. McCullough, M. J. Clague and S. Urbe: AMSH is an endosome-associated ubiquitin isopeptidase. J Cell Biol, 166(4), 487-92 (2004)
88. B. Hasdemir, J. E. Murphy, G. S. Cottrell and N. W. Bunnett: Endosomal deubiquitinating enzymes control ubiquitination and down-regulation of protease-activated receptor 2. J Biol Chem, 284(41), 28453-66 (2009)
89. J. N. Hislop, A. G. Henry, A. Marchese and M. von Zastrow: Ubiquitination regulates proteolytic processing of G protein-coupled receptors after their sorting to lysosomes. J Biol Chem, 284(29), 19361-70 (2009)
90. Y. M. Ma, E. Boucrot, J. Villen, B. Affar el, S. P. Gygi, H. G. Gottlinger and T. Kirchhausen: Targeting of AMSH to endosomes is required for epidermal growth factor receptor degradation. J Biol Chem, 282(13), 9805-12 (2007)
91. H. A. Alwan and J. E. van Leeuwen: UBPY-mediated epidermal growth factor receptor (EGFR) de-ubiquitination promotes EGFR degradation. J Biol Chem, 282(3), 1658-69 (2007)
92. S. Naviglio, C. Mattecucci, B. Matoskova, T. Nagase, N. Nomura, P. P. Di Fiore and G. F. Draetta: UBPY: a growth-regulated human ubiquitin isopeptidase. Embo J, 17(12), 3241-50 (1998)
93. A. Meenhuis, C. Verwijmeren, O. Roovers and I. P. Touw: The deubiquitinating enzyme DUB2A enhances CSF3 signalling by attenuating lysosomal routing of the CSF3 receptor. Biochem J, 434(2), 343-51 (2011)
94. K. H. Baek, M. S. Kim, Y. S. Kim, J. M. Shin and H. K. Choi: DUB-1A, a novel deubiquitinating enzyme subfamily member, is polyubiquitinated and cytokine-inducible in B-lymphocytes. J Biol Chem, 279(4), 2368-76 (2004)
95. K. H. Baek, M. A. Mondoux, R. Jaster, E. Fire-Levin and A. D. D'Andrea: DUB-2A, a new member of the DUB subfamily of hematopoietic deubiquitinating enzymes. Blood, 98(3), 636-42 (2001)
96. Y. Zhu, K. Lambert, C. Corless, N. G. Copeland, D. J. Gilbert, N. A. Jenkins and A. D. D'Andrea: DUB-2 is a member of a novel family of cytokine-inducible deubiquitinating enzymes. J Biol Chem, 272(1), 51-7 (1997)
97. Y. Zhu, M. Pless, R. Inhorn, B. Mathey-Prevot and A. D. D'Andrea: The murine DUB-1 gene is specifically induced by the betac subunit of interleukin-3 receptor. Mol Cell Biol, 16(9), 4808-17 (1996)
98. M. Y. Lee, B. S. Ajjappala, M. S. Kim, Y. K. Oh and K. H. Baek: DUB-1, a fate determinant of dynein heavy chain in B-lymphocytes, is regulated by the ubiquitin-proteasome pathway. J Cell Biochem, 105(6), 1420-9 (2008)
99. T. Shima, T. Kon, K. Imamula, R. Ohkura and K. Sutoh: Two modes of microtubule sliding driven by cytoplasmic dynein. Proc Natl Acad Sci U S A, 103(47), 17736-40 (2006)
100. E. Bananis, S. Nath, K. Gordon, P. Satir, R. J. Stockert, J. W. Murray and A. W. Wolkoff: Microtubule-dependent movement of late endocytic vesicles in vitro : requirements for Dynein and Kinesin. Mol Biol Cell, 15(8), 3688-97 (2004)
101. O. J. Driskell, A. Mironov, V. J. Allan and P. G. Woodman: Dynein is required for receptor sorting and the morphogenesis of early endosomes. Nat Cell Biol, 9(1), 113-20 (2007)
102. M. David, H. E. Chen, S. Goelz, A. C. Larner and B. G. Neel: Differential regulation of the alpha/beta interferon-stimulated Jak/Stat pathway by the SH2 domain-containing tyrosine phosphatase SHPTP1. Mol Cell Biol, 15(12), 7050-8 (1995)
103. H. W. Tsui, K. A. Siminovitch, L. de Souza and F. W. Tsui: Motheaten and viable motheaten mice have mutations in the haematopoietic cell phosphatase gene. Nat Genet, 4(2), 124-9 (1993)
104. T. L. Yi, J. L. Cleveland and J. N. Ihle: Protein tyrosine phosphatase containing SH2 domains: characterization, preferential expression in hematopoietic cells, and localization to human chromosome 12p12-p13. Mol Cell Biol, 12(2), 836-46 (1992)
105. B. G. Neel, H. Gu and L. Pao: The 'Shp'ing news: SH2 domain-containing tyrosine phosphatases in cell signaling. Trends Biochem Sci, 28(6), 284-93 (2003)
106. D. He, X. Song, L. Liu, D. H. Burk and G. W. Zhou: EGF-stimulation activates the nuclear localization signal of SHP-1. J Cell Biochem, 94(5), 944-53 (2005)
107. F. Dong, Y. Qiu, T. Yi, I. P. Touw and A. C. Larner: The carboxyl terminus of the granulocyte colony-stimulating factor receptor, truncated in patients with severe congenital neutropenia/acute myeloid leukemia, is required for SH2-containing phosphatase-1 suppression of Stat activation. J Immunol, 167((11), 6447-52 (2001)
108. P. Tapley, N. K. Shevde, P. A. Schweitzer, M. Gallina, S. W. Christianson, I. L. Lin, R. B. Stein, L. D. Shultz, J. Rosen and P. Lamb: Increased G-CSF responsiveness of bone marrow cells from hematopoietic cell phosphatase deficient viable motheaten mice. Exp Hematol, 25(2), 122-31 (1997)
109. A. C. Ward, S. P. Oomen, L. Smith, J. Gits, D. van Leeuwen, A. A. Soede-Bobok, C. A. Erpelinck-Verschueren, T. Yi and I. P. Touw: The SH2 domain-containing protein tyrosine phosphatase SHP-1 is induced by granulocyte colony-stimulating factor (G-CSF) and modulates signaling from the G-CSF receptor. Leukemia, 14(7), 1284-91 (2000)
110. A. C. Ward, L. Smith, J. P. de Koning, Y. van Aesch and I. P. Touw: Multiple signals mediate proliferation, differentiation, and survival from the granulocyte colony-stimulating factor receptor in myeloid 32D cells. J Biol Chem, 274(21), 14956-62 (1999)
111. C. L. Yu, Y. J. Jin and S. J. Burakoff: Cytosolic tyrosine dephosphorylation of STAT5. Potential role of SHP-2 in STAT5 regulation. J Biol Chem, 275(1), 599-604 (2000)
112. M. Futami, Q. S. Zhu, Z. L. Whichard, L. Xia, Y. Ke, B. G. Neel, G. S. Feng and S. J. Corey: G-CSF receptor activation of the Src kinase Lyn is mediated by Gab2 recruitment of the Shp2 phosphatase. Blood, 118(4), 1077-86 (2011)
113. M. Dance, A. Montagner, J. P. Salles, A. Yart and P. Raynal: The molecular functions of Shp2 in the Ras/Mitogen-activated protein kinase (ERK1/2) pathway. Cell Signal, 20(3), 453-9 (2008)
114. F. Dong, X. Liu, J. P. de Koning, I. P. Touw, L. Hennighausen, A. Larner and P. M. Grimley: Stimulation of Stat5 by granulocyte colony-stimulating factor (G-CSF) is modulated by two distinct cytoplasmic regions of the G-CSF receptor. J Immunol, 161(12), 6503-9 (1998)
115. A. B. Hunter MG: Phosphatidylinositol 3′-kinase and SH2-containing inositol phosphatase (SHIP) are recruited by distinct positive and negative growth-regulatory domains in the granulocyte colony-stimulating factor receptor. J Immunol, 160(10), 4979-87 (1998)
116. N. J. Pumphrey, V. Taylor, S. Freeman, M. R. Douglas, P. F. Bradfield, S. P. Young, J. M. Lord, M. J. Wakelam, I. N. Bird, M. Salmon and C. D. Buckley: Differential association of cytoplasmic signalling molecules SHP-1, SHP-2, SHIP and phospholipase Cgamma1 with PECAM-1/CD31. FEBS Lett, 450(1-2), 77-83 (1999)
117. C. D. Helgason, J. E. Damen, P. Rosten, R. Grewal, P. Sorensen, S. M. Chappel, A. Borowski, F. Jirik, G. Krystal and R. K. Humphries: Targeted disruption of SHIP leads to hemopoietic perturbations, lung pathology, and a shortened life span. Genes Dev, 12(11), 1610-20 (1998)
118. Q. Liu, T. Sasaki, I. Kozieradzki, A. Wakeham, A. Itie, D. J. Dumont and J. M. Penninger: SHIP is a negative regulator of growth factor receptor-mediated PKB/Akt activation and myeloid cell survival. Genes Dev, 13(7), 786-91 (1999)
119. M. Stuible and M. L. Tremblay: In control at the ER: PTP1B and the down-regulation of RTKs by dephosphorylation and endocytosis. Trends Cell Biol, 20(11), 672-9 (2010)
120. J. V. Frangioni, P. H. Beahm, V. Shifrin, C. A. Jost and B. G. Neel: The nontransmembrane tyrosine phosphatase PTP-1B localizes to the endoplasmic reticulum via its 35 amino acid C-terminal sequence. Cell, 68(3), 545-60 (1992)
121. T. A. Woodford-Thomas, J. D. Rhodes and J. E. Dixon: Expression of a protein tyrosine phosphatase in normal and v-src-transformed mouse 3T3 fibroblasts. J Cell Biol, 117(2), 401-14 (1992)
122. F. G. Haj, P. J. Verveer, A. Squire, B. G. Neel and P. I. Bastiaens: Imaging sites of receptor dephosphorylation by PTP1B on the surface of the endoplasmic reticulum. Science, 295(5560), 1708-11 (2002)
123. G. Gill: A pit stop at the ER. Science, 295(5560), 1654-5 (2002)
124. M. P. Myers, J. N. Andersen, A. Cheng, M. L. Tremblay, C. M. Horvath, J. P. Parisien, A. Salmeen, D. Barford and N. K. Tonks: TYK2 and JAK2 are substrates of protein-tyrosine phosphatase 1B. J Biol Chem, 276(51), 47771-4 (2001)
125. J. M. Zabolotny, K. K. Bence-Hanulec, A. Stricker-Krongrad, F. Haj, Y. Wang, Y. Minokoshi, Y. B. Kim, J. K. Elmquist, L. A. Tartaglia, B. B. Kahn and B. G. Neel: PTP1B regulates leptin signal transduction in vivo . Dev Cell, 2(4), 489-95 (2002)
126. K. J. Johnson, A. R. Peck, C. Liu, T. H. Tran, F. E. Utama, A. B. Sjolund, J. D. Schaber, A. K. Witkiewicz and H. Rui: PTP1B suppresses prolactin activation of Stat5 in breast cancer cells. Am J Pathol, 177(6), 2971-83 (2010)
127. X. Lu, R. Malumbres, B. Shields, X. Jiang, K. A. Sarosiek, Y. Natkunam, T. Tiganis and I. S. Lossos: PTP1B is a negative regulator of interleukin 4-induced STAT6 signaling. Blood, 112(10), 4098-108 (2008)
128. J. Cohen, L. Oren-Young, U. Klingmuller and D. Neumann: Protein tyrosine phosphatase 1B participates in the down-regulation of erythropoietin receptor signalling. Biochem J, 377(Pt 2), 517-24 (2004)
129. K. Palande, O. Roovers, J. Gits, C. Verwijmeren, Y. Iuchi, J. Fujii, B. G. Neel, R. Karisch, J. Tavernier and I. P. Touw: Peroxiredoxin-controlled G-CSF signalling at the endoplasmic reticulum-early endosome interface. J Cell Sci (2011)
130. N. Tonks: Protein tyrosine phosphatases: from genes, to function, to disease. Nat Rev Mol Cell Biol, 7(11), 833-46 (2006)
131. N. K. Tonks: Redox redux: revisiting PTPs and the control of cell signaling. Cell, 121(5), 667-70 (2005)
132. A. Groen, S. Lemeer, T. van der Wijk, J. Overvoorde, A. J. Heck, A. Ostman, D. Barford, M. Slijper and J. den Hertog: Differential oxidation of protein-tyrosine phosphatases. J Biol Chem, 280(11), 10298-304 (2005)
133. K. Bedard and K. H. Krause: The NOX family of ROS-generating NADPH oxidases: physiology and pathophysiology. Physiol Rev, 87(1), 245-313 (2007)
134. Q. Li, M. M. Harraz, W. Zhou, L. N. Zhang, W. Ding, Y. Zhang, T. Eggleston, C. Yeaman, B. Banfi and J. F. Engelhardt: Nox2 and Rac1 regulate H2O2-dependent recruitment of TRAF6 to endosomal interleukin-1 receptor complexes. Mol Cell Biol, 26(1), 140-54 (2006)
135. K. Chen, M. T. Kirber, H. Xiao, Y. Yang and J. F. J. Keaney: Regulation of ROS signal transduction by NADPH oxidase 4 localization. J Cell Biol, 181(7), 1129-39 (2008)
136. K. Mahadev, A. Zilbering, L. Zhu and B. J. Goldstein: Insulin-stimulated hydrogen peroxide reversibly inhibits protein-tyrosine phosphatase 1b in vivo and enhances the early insulin action cascade. J Biol Chem, 276(4), 21938-42 (2001)
137. T. C. Meng, D. A. Buckley, S. Galic, T. Tiganis and N. K. Tonks: Regulation of insulin signaling through reversible oxidation of the protein-tyrosine phosphatases TC45 and PTP1B. J Biol Chem, 279(36), 37716-25 (2004)
138. P. Sharma, R. Chakraborty, L. Wang, B. Min, M. L. Tremblay, T. Kawahara, J. D. Lambeth and S. J. Haque: Redox regulation of interleukin-4 signaling. Immunity, 29(4), 551-64 (2008)
139. M. H. Choi, I. K. Lee, G. W. Kim, B. U. Kim, Y. H. Han, D. Y. Yu, H. S. Park, K. Y. Kim, J. S. Lee, C. Choi, Y. S. Bae, B. I. Lee, S. G. Rhee and S. W. Kang: Regulation of PDGF signalling and vascular remodelling by peroxiredoxin II. Nature, 435(7040), 347-53 (2005)
140. H. A. Woo, S. H. Yim, D. H. Shin, D. Kang, D. Y. Yu and S. G. Rhee: Inactivation of peroxiredoxin I by phosphorylation allows localized H(2)O(2) accumulation for cell signaling. Cell, 140(4), 517-28 (2010)
141. T. J. Tavender, A. M. Sheppard and N. J. Bulleid: Peroxiredoxin IV is an endoplasmic reticulum-localized enzyme forming oligomeric complexes in human cells. Biochem J, 411(1), 191-9 (2008)
142. A. Meenhuis, P. A. van Veelen, H. de Looper, N. van Boxtel, I. J. van den Berge, S. M. Sun, E. Taskesen, P. Stern, A. H. de Ru, A. J. van Adrichem, J. Demmers, M. Jongen-Lavrencic, B. Lowenberg, I. P. Touw, P. A. Sharp and S. J. Erkeland: MiR-17/20/93/106 promote hematopoietic cell expansion by targeting sequestosome 1-regulated pathways in mice. Blood, 118(4), 916-25 (2011)
143. Q. S. Zhu, L. Xia, G. B. Mills, C. A. Lowell, I. P. Touw and S. J. Corey: G-CSF induced reactive oxygen species involves Lyn-PI3-kinase-Akt and contributes to myeloid cell growth. Blood, 107(5), 1847-56 (2006)
144. M. Harada, Y. Qin, H. Takano, T. Minamino, Y. Zou, H. Toko, M. Ohtsuka, K. Matsuura, M. Sano, J. Nishi, K. Iwanaga, H. Akazawa, T. Kunieda, W. Zhu, H. Hasegawa, K. Kunisada, T. Nagai, H. Nakaya, K. Yamauchi-Takihara and I. Komuro: G-CSF prevents cardiac remodeling after myocardial infarction by activating the Jak-Stat pathway in cardiomyocytes. Nat Med, 11(3), 305-11 (2005)
145. M. Hasselblatt, A. Jeibmann, B. Riesmeier, D. Maintz and W. R. Schabitz: Granulocyte-colony stimulating factor (G-CSF) and G-CSF receptor expression in human ischemic stroke. Acta Neuropathol, 113(1), 45-51 (2007)
146. A. Schneider, C. Kruger, T. Steigleder, D. Weber, C. Pitzer, R. Laage, J. Aronowski, M. H. Maurer, N. Gassler, W. Mier, M. Hasselblatt, R. Kollmar, S. Schwab, C. Sommer, A. Bach, H. G. Kuhn and W. R. Schabitz: The hematopoietic factor G-CSF is a neuronal ligand that counteracts programmed cell death and drives neurogenesis. J Clin Invest, 115(8), 2083-98 (2005)
147. M. M. Zaruba, H. D. Theiss, M. Vallaster, U. Mehl, S. Brunner, R. David, R. Fischer, L. Krieg, E. Hirsch, B. Huber, P. Nathan, L. Israel, A. Imhof, N. Herbach, G. Assmann, R. Wanke, J. Mueller-Hoecker, G. Steinbeck and W. M. Franz: Synergy between CD26/DPP-IV inhibition and G-CSF improves cardiac function after acute myocardial infarction. Cell Stem Cell, 4(4), 313-23 (2009)
148. E. R. Eden, I. J. White and A. a. F. Tsapara, C.E.: Membrane contacts between endosomes and ER provide sites for PTP1B - epidermal growth factor receptor interaction. Nat Cell Biol, 12(3), 267-72 (2010)
149. V. Sangwan, J. Abella, A. Lai, N. Bertos, M. Stuible, M. L. Tremblay and M. Park: Protein tyrosine phosphatase PTP1B modulates early endosome fusion and trafficking of Met and EGF receptor tyrosine kinases. J Biol Chem (2011)